![](/img/cover-not-exists.png)
Sacituzumab govitecan (IMMU-132) in uterine serous carcinoma
Han, C., Bianchi, A., Bellone, S., Altwerger, G., Menderes, G., Zeybek, B., Haines, K., Lopez, S., Azodi, M., Litkouhi, B., Silasi, D.A., Huang, G.S., Ratner, E.S., Schwartz, P.E., Santin, A.D.Volume:
154
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2019.04.152
Date:
June, 2019
File:
PDF, 53 KB
2019